{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:37:15Z","timestamp":1775173035280,"version":"3.50.1"},"reference-count":424,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymgme.2025.109125","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:28:49Z","timestamp":1746059329000},"page":"109125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["European guidelines on diagnosis and treatment of phenylketonuria: First revision"],"prefix":"10.1016","volume":"145","author":[{"given":"A.M.J.","family":"van Wegberg","sequence":"first","affiliation":[]},{"given":"A.","family":"MacDonald","sequence":"additional","affiliation":[]},{"given":"K.","family":"Ahring","sequence":"additional","affiliation":[]},{"given":"A.","family":"B\u00e9langer-Quintana","sequence":"additional","affiliation":[]},{"given":"S.","family":"Beblo","sequence":"additional","affiliation":[]},{"given":"N.","family":"Blau","sequence":"additional","affiliation":[]},{"given":"A.M.","family":"Bosch","sequence":"additional","affiliation":[]},{"given":"A.","family":"Burlina","sequence":"additional","affiliation":[]},{"given":"J.","family":"Campistol","sequence":"additional","affiliation":[]},{"given":"T.","family":"Co\u015fkun","sequence":"additional","affiliation":[]},{"given":"F.","family":"Feillet","sequence":"additional","affiliation":[]},{"given":"M.","family":"Gi\u017cewska","sequence":"additional","affiliation":[]},{"given":"S.C.","family":"Huijbregts","sequence":"additional","affiliation":[]},{"given":"V.","family":"Leuzzi","sequence":"additional","affiliation":[]},{"given":"F.","family":"Maillot","sequence":"additional","affiliation":[]},{"given":"A.C.","family":"Muntau","sequence":"additional","affiliation":[]},{"given":"J.C.","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"C.","family":"Romani","sequence":"additional","affiliation":[]},{"given":"F.","family":"Trefz","sequence":"additional","affiliation":[]},{"given":"F.J.","family":"van Spronsen","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jimd.12065","article-title":"The neurological and psychological phenotype of adult patients with early-treated phenylketonuria: a systematic review","volume":"42","author":"Burlina","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13023-018-0839-x","article-title":"Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis","volume":"13","author":"Montoya Parra","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104925","article-title":"Meta-analyses of cognitive functions in early-treated adults with phenylketonuria","volume":"143","author":"Romani","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb0025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","article-title":"Key European guidelines for the diagnosis and management of patients with phenylketonuria","volume":"5","author":"van Spronsen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","article-title":"PKU dietary handbook to accompany PKU guidelines","volume":"15","author":"MacDonald","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2009.09.005","article-title":"Management of phenylketonuria in Europe: survey results from 19 countries","volume":"99","author":"Blau","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1750-1172-8-191","article-title":"Requirements for a minimum standard of care for phenylketonuria: the patients\u2019 perspective","volume":"8","author":"Hagedorn","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10545-008-0966-y","article-title":"PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders","volume":"32","author":"van Spronsen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-8587(17)30201-2","article-title":"Issues with European guidelines for phenylketonuria","volume":"5","author":"Burgard","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.24953\/turkjped.2021.4098","article-title":"Recommendations on phenylketonuria in Turkey","volume":"64","author":"Coskun","year":"2022","journal-title":"Turk. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030576","article-title":"Dietetic Management of Adults with phenylketonuria (PKU) in the UK: a care consensus document","volume":"14","author":"Robertson","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1515\/jpem-2018-0527","article-title":"The European phenylketonuria guidelines and the challenges on management practices in Portugal","volume":"32","author":"Sousa","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113319","article-title":"Nutrition, microbiota and role of gut-brain axis in subjects with phenylketonuria (PKU): a review","volume":"12","author":"Verduci","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2019-106278","article-title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines","volume":"57","author":"Leuzzi","year":"2020","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13023-018-0890-7","article-title":"Can untreated PKU patients escape from intellectual disability? A systematic review","volume":"13","author":"van Vliet","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112572","article-title":"Untreated PKU patients without intellectual disability: what do they teach us?","volume":"11","author":"van Vliet","year":"2019","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.ymgme.2025.109125_bb0095","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00415-014-7492-7","article-title":"Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism","volume":"261","author":"Rosini","year":"2014","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13554794.2016.1142567","article-title":"Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism","volume":"22","author":"Tufekcioglu","year":"2016","journal-title":"Neurocase"},{"key":"10.1016\/j.ymgme.2025.109125_bb0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijbiomac.2020.10.218","article-title":"Paper-based biosensor based on phenylalnine ammonia lyase hybrid nanoflowers for urinary phenylalanine measurement","volume":"166","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"29","key":"10.1016\/j.ymgme.2025.109125_bb0110","doi-asserted-by":"crossref","first-page":"8825","DOI":"10.1007\/s00216-015-9041-3","article-title":"A GC\/MS-based metabolomic approach for reliable diagnosis of phenylketonuria","volume":"407","author":"Xiong","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0115","doi-asserted-by":"crossref","first-page":"14615","DOI":"10.4238\/2015.November.18.25","article-title":"Prenatal diagnosis of Chinese families with phenylketonuria","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"231\u20134","key":"10.1016\/j.ymgme.2025.109125_bb0120","article-title":"Undiagnosed phenylketonuria can exist everywhere: results from an international survey","volume":"239","author":"van Wegberg","year":"2021","journal-title":"J. Pediatr."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2025.109125_bb0125","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ymgme.2013.08.014","article-title":"Undiagnosed phenylketonuria in parents of phenylketonuric patients, is it worthwhile to be checked?","volume":"110","author":"Wiedemann","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00431-019-03387-8","article-title":"Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management","volume":"178","author":"Yildiz","year":"2019","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0135","doi-asserted-by":"crossref","DOI":"10.36295\/ASRO.2020.23130","article-title":"Clinicodemographic study of phenylketonuria (PKU) in al-emamain al-khadimaiyn Medical City (rare disease unit) Baghdad, Iraq","volume":"23","author":"Al-Tai","year":"2020","journal-title":"Ann. Trop. Med. Publ. Health"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jpc.13469","article-title":"Expanded newborn screening program in Saudi Arabia: incidence of screened disorders","volume":"53","author":"Alfadhel","year":"2017","journal-title":"J. Paediatr. Child Health"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ajmg.c.31899","article-title":"Newborn screening in Latin America: a brief overview of the state of the art","volume":"187","author":"Borrajo","year":"2021","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0150","first-page":"49","article-title":"Assessing the phenylketonuria screening program in newborns, Iran 2015-2016","volume":"56","author":"Ganji","year":"2018","journal-title":"Acta Med. Iran"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00431-015-2622-5","article-title":"Diagnostic and management practices for phenylketonuria in 19 countries of the south and eastern European region: survey results","volume":"175","author":"Gizewska","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109125_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.648939","article-title":"Current status of newborn screening in southeastern Europe","volume":"9","author":"Koracin","year":"2021","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijns7010015","article-title":"Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010","volume":"7","author":"Loeber","year":"2021","journal-title":"Int. J. Neonatal. Screen."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0170","first-page":"509","article-title":"Retrospective study of patients with Hyperphenylalaninemia- experience from a tertiary Care Center in Pakistan","volume":"69","author":"Ahmed","year":"2019","journal-title":"J. Pak. Med. Assoc."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5001\/omj.2019.59","article-title":"Inborn errors of metabolism in children with unexplained developmental delay in Misan, Iraq","volume":"34","author":"Altimimi","year":"2019","journal-title":"Oman Med. J."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0883073810375116","article-title":"Experience with hyperphenylalaninemia in a developing country: unusual clinical manifestations and a novel gene mutation","volume":"26","author":"Karam","year":"2011","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2025.109125_bb0185","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2147\/NDT.S176198","article-title":"Clinical and neuropsychological outcomes for children with phenylketonuria in upper Egypt; a single-center study over 5 years","volume":"14","author":"Sadek","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.24953\/turkjped.2016.01.014","article-title":"Late-diagnosed phenylketonuria in an eight-year-old boy with dyslexia and attention-deficit hyperactivity disorder","volume":"58","author":"Yildiz","year":"2016","journal-title":"Turk. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-0038-1661415","article-title":"Neurological sequelae due to inborn metabolic diseases in pediatric refugees: challenges in treating the untreated","volume":"49","author":"Schiergens","year":"2018","journal-title":"Neuropediatrics"},{"issue":"Suppl","key":"10.1016\/j.ymgme.2025.109125_bb0200","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ymgme.2011.08.025","article-title":"Adult phenylketonuria outcome and management","volume":"104","author":"Trefz","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0205","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3994","article-title":"Learning problems in children of refugee background: a systematic review","volume":"137","author":"Graham","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1363461515612933","article-title":"Cognitive assessment of refugee children: effects of trauma and new language acquisition","volume":"53","author":"Kaplan","year":"2016","journal-title":"Transcult. Psychiatry"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0215","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ajhg.2017.01.002","article-title":"Biallelic mutations in DNAJC12 cause Hyperphenylalaninemia, dystonia, and intellectual disability","volume":"100","author":"Anikster","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109125_bb0220","first-page":"99","article-title":"Beneficial effect of BH(4) treatment in a 15-year-old boy with Biallelic mutations in DNAJC12","volume":"42","author":"de Sain-van der Velden","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb0225","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cca.2018.09.002","article-title":"Identification of an inherited pathogenic DNAJC12 variant in a patient with hyperphenylalalinemia","volume":"490","author":"Feng","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb0230","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/humu.24026","article-title":"Pathogenic variants of DNAJC12 and evaluation of the encoded cochaperone as a genetic modifier of hyperphenylalaninemia","volume":"41","author":"Gallego","year":"2020","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1303","article-title":"Two novel mutations in DNAJC12 identified by whole-exome sequencing in a patient with mild hyperphenylalaninemia","volume":"8","author":"Li","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.ymgme.2025.109125_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpn.2020.07.011","article-title":"Phenylalanine and tyrosine metabolism in DNAJC12 deficiency: a comparison between inherited hyperphenylalaninemias and healthy subjects","volume":"28","author":"Porta","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0245","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.25048","article-title":"DNAJC12 and dopa-responsive nonprogressive parkinsonism","volume":"82","author":"Straniero","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2025.109125_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jmedgenet-2017-104875","article-title":"Heterogeneous clinical spectrum of DNAJC12-deficient hyperphenylalaninemia: from attention deficit to severe dystonia and intellectual disability","volume":"55","author":"van Spronsen","year":"2018","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109125_bb0255","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41431-018-0237-9","article-title":"DNAJC12-associated developmental delay, movement disorder, and mild hyperphenylalaninemia identified by whole-exome sequencing re-analysis","volume":"26","author":"Veenma","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.11.005","article-title":"DNAJC12 deficiency: a new strategy in the diagnosis of hyperphenylalaninemias","volume":"123","author":"Blau","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0265","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1038\/s41467-021-25515-5","article-title":"Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines","volume":"12","author":"Kuseyri Hubschmann","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0270","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0275","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41390-021-01728-8","article-title":"Metabolic control during the neonatal period in phenylketonuria: associations with childhood IQ","volume":"91","author":"Liemburg","year":"2022","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0280","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","article-title":"Intelligence and quality of dietary treatment in phenylketonuria","volume":"65","author":"Smith","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2025.109125_bb0285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1651-2227.1994.tb13455.x","article-title":"The phenylalanine response curve in relation to growth and mental development in the first year of life","volume":"407","author":"van der Schot","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb0290","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/PL00014251","article-title":"Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak collaborative study","volume":"155","author":"Zeman","year":"1996","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2017.10.010","article-title":"\u201cmild\u201d hyperphenylalaninemia? A case series of seven treated patients following newborn screening","volume":"122","author":"Viall","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0305","first-page":"72","article-title":"Cognitive functioning in mild hyperphenylalaninemia","volume":"5","author":"de la Parra","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0310","doi-asserted-by":"crossref","first-page":"617","DOI":"10.24953\/turkjped.2018.06.001","article-title":"Cognitive and behavioral impairment in mild hyperphenylalaninemia","volume":"60","author":"Evinc","year":"2018","journal-title":"Turk. J. Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb0315","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1007\/s10072-022-06194-6","article-title":"Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review","volume":"43","author":"Rostampour","year":"2022","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0320","first-page":"69","article-title":"Psychological well-being of early and continuously treated phenylketonuria patients","volume":"59","author":"Thiele","year":"2021","journal-title":"JIMD Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0325","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jimd.12528","article-title":"Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: a comparison between two genetic disorders affecting the same metabolic pathway","volume":"45","author":"van Vliet","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0330","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1037\/neu0000358","article-title":"Cognitive profile and mental health in adult phenylketonuria: a PKU-COBESO study","volume":"31","author":"Jahja","year":"2017","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-016-9918-0","article-title":"Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study","volume":"39","author":"Jahja","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0340","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10519-017-9863-1","article-title":"Long-term follow-up of cognition and mental health in adult phenylketonuria: a PKU-COBESO study","volume":"47","author":"Jahja","year":"2017","journal-title":"Behav. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0345","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13023-019-1225-z","article-title":"Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels","volume":"14","author":"Romani","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0350","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ymgme.2018.12.011","article-title":"Neurocognitive functioning in adults with phenylketonuria: report of a 10-year follow-up","volume":"126","author":"Feldmann","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"2\u20133","key":"10.1016\/j.ymgme.2025.109125_bb0355","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.04.003","article-title":"Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: a longitudinal study","volume":"115","author":"Nardecchia","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0360","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10545-017-0082-y","article-title":"Predictability and inconsistencies in the cognitive outcome of early treated PKU patients","volume":"40","author":"Manti","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1037\/neu0000337","article-title":"Cognitive outcomes in early-treated adults with phenylketonuria (PKU): a comprehensive picture across domains","volume":"31","author":"Palermo","year":"2017","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0370","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/neu0000336","article-title":"The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: effects across tasks and developmental stages","volume":"31","author":"Romani","year":"2017","journal-title":"Neuropsychology"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0375","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jimd.12413","article-title":"Long-term cognitive and psychosocial outcomes in adults with phenylketonuria","volume":"44","author":"Aitkenhead","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb0380","first-page":"23","article-title":"The use of d2 and Benton tests for assessment of attention deficits and visual memory in teenagers with phenylketonuria","volume":"40","author":"Didycz","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.664525","article-title":"A retrospective case series analysis of the relationship between phenylalanine: tyrosine ratio and cerebral glucose metabolism in classical phenylketonuria and Hyperphenylalaninemia","volume":"15","author":"McGinnity","year":"2021","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0390","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1212\/WNL.0000000000011088","article-title":"Phenylalanine effects on brain function in adult phenylketonuria","volume":"96","author":"Pilotto","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13023-020-01668-2","article-title":"The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study","volume":"16","author":"Burgess","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0405","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s13023-021-02138-z","article-title":"Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre","volume":"16","author":"Altman","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0410","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ajmg.a.62574","article-title":"Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria","volume":"188","author":"Bilder","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2025.109125_bb0415","first-page":"77","article-title":"Improved measurement of brain phenylalanine and tyrosine related to neuropsychological functioning in phenylketonuria","volume":"34","author":"Waisbren","year":"2017","journal-title":"JIMD Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb0420","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004310050945","article-title":"Neurological outcome in adult patients with early-treated phenylketonuria","volume":"157","author":"Pietz","year":"1998","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0425","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00415-019-09608-2","article-title":"Neurological manifestations in adults with phenylketonuria: new cases and review of the literature","volume":"267","author":"Jaulent","year":"2020","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0430","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13803395.2019.1696753","article-title":"Emotional health in early-treated adults with phenylketonuria (PKU): relationship with cognitive abilities and blood phenylalanine","volume":"42","author":"Palermo","year":"2020","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb0435","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0301-2115(03)00172-6","article-title":"Placental transport of amino acids in normal and growth-restricted pregnancies","volume":"110","author":"Cetin","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11100680","article-title":"Differences of phenylalanine concentrations in dried blood spots and in plasma: erythrocytes as a neglected component for this observation","volume":"11","author":"Haas","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13023-020-1343-7","article-title":"Dried blood spot versus venous blood sampling for phenylalanine and tyrosine","volume":"15","author":"van Vliet","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2022.08.005","article-title":"Evaluation of volumetric blood collection devices for the measurement of phenylalanine and tyrosine to monitor patients with phenylketonuria","volume":"535","author":"Carling","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0455","first-page":"70","article-title":"Monitoring phenylalanine concentrations in the follow-up of phenylketonuria patients: an inventory of pre-analytical and analytical variation","volume":"58","author":"Coene","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.155116","article-title":"PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study","volume":"128","author":"Bratkovic","year":"2022","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0465","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18388\/abp.2017_1524","article-title":"Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria","volume":"64","author":"Didycz","year":"2017","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ymgme.2025.109125_bb0470","first-page":"80","article-title":"Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria","volume":"14","author":"Didycz","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0475","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/apa.14517","article-title":"Children and adolescents with phenylketonuria display fluctuations in their blood phenylalanine levels","volume":"108","author":"Feldmann","year":"2019","journal-title":"Acta Paediatr."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103033","article-title":"Cognitive outcomes and relationships with phenylalanine in phenylketonuria: a comparison between Italian and English adult samples","volume":"12","author":"Romani","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb0485","first-page":"87","article-title":"Executive function in adolescents with PKU and their siblings: associations with biochemistry","volume":"4","author":"Sharman","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0490","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jimd.12049","article-title":"Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria","volume":"42","author":"Pilotto","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0495","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2014.03.061","article-title":"Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation","volume":"165","author":"Yano","year":"2014","journal-title":"J. Pediatr."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2019.05.017","article-title":"Clinical characterization of tremor in patients with phenylketonuria","volume":"128","author":"Nardecchia","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0505","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2019.03.005","article-title":"Direct-infusion based metabolomics unveils biochemical profiles of inborn errors of metabolism in cerebrospinal fluid","volume":"127","author":"Haijes","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0510","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10545-015-9843-7","article-title":"Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism","volume":"38","author":"Miller","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb0515","article-title":"Telehealth and COVID-19: empowering standards of Management for Patients Affected by phenylketonuria and Hyperphenylalaninemia","volume":"9","author":"Rovelli","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb0520","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1515\/jpem-2020-0025","article-title":"Morning specimen is not representative of metabolic control in Tunisian children with phenylketonuria: a repeated cross-sectional study","volume":"33","author":"Ben Abdelaziz","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0525","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2891-12-60","article-title":"Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations","volume":"12","author":"Grunert","year":"2013","journal-title":"Nutr. J."},{"key":"10.1016\/j.ymgme.2025.109125_bb0530","first-page":"13","article-title":"Ready, steady, go - achieving successful transition in cystic fibrosis","volume":"27","author":"Connett","year":"2018","journal-title":"Paediatr. Respir. Rev."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0535","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2022.04.004","article-title":"The management of transitional care of patients affected by phenylketonuria in Italy: review and expert opinion","volume":"136","author":"Biasucci","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0540","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jadohealth.2022.03.010","article-title":"Two-year follow-up of a transition-specific education program for Young people with chronic conditions","volume":"71","author":"Ernst","year":"2022","journal-title":"J. Adolesc. Health"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030799","article-title":"Implementing a transition program from Paediatric to adult Services in Phenylketonuria: results after two years of follow-up with an adult team","volume":"13","author":"Peres","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb0550","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13023-016-0410-6","article-title":"Ten years of specialized adult care for phenylketonuria - a single-Centre experience","volume":"11","author":"Mutze","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2021.05.003","article-title":"Project \u201cBacktoclinic I\u201d: an overview on the state of care of adult PKU patients in Austria","volume":"133","author":"Beghini","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0560","article-title":"Strategies to engage lost to follow-up patients with phenylketonuria in the United States: best practice recommendations","volume":"23","author":"Beazer","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb0565","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymgme.2022.07.012","article-title":"Management of early treated adolescents and young adults with phenylketonuria: development of international consensus recommendations using a modified Delphi approach","volume":"137","author":"Burton","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0570","first-page":"5","article-title":"Strategies for successful long-term engagement of adults with phenylalanine hydroxylase deficiency returning to the clinic","author":"Thomas","year":"2017","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"10.1016\/j.ymgme.2025.109125_bb0575","article-title":"Challenges in transition from childhood to adulthood Care in Rare Metabolic Diseases: results from the first multi-center European survey","volume":"8","author":"Stepien","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0580","first-page":"118","article-title":"Treatment of classic phenylketonuria in Poland in the years 2009-2015 based on the database of the Polish National Health Fund. Pediatr Endocrinol","volume":"26","author":"Szypowska","year":"2020","journal-title":"Diabetes Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0585","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1037\/a0029419","article-title":"Processing speed and executive abilities in children with phenylketonuria","volume":"26","author":"Janos","year":"2012","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0590","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ymgme.2014.01.012","article-title":"Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria","volume":"111","author":"Hood","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0595","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/1467-8624.00370","article-title":"Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria","volume":"72","author":"Luciana","year":"2001","journal-title":"Child Dev."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0600","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1651-2227.1995.tb13661.x","article-title":"Neurological findings in early treated phenylketonuria","volume":"84","author":"Weglage","year":"1995","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2025.109125_bb0605","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1477-7525-11-218","article-title":"Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride","volume":"11","author":"Douglas","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0610","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s12325-021-01986-2","article-title":"Measuring burden of illness in phenylketonuria (PKU): development of the PKU symptom severity and impacts scale as a robust patient-reported outcome","volume":"39","author":"Quinn","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ymgme.2025.109125_bb0615","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1186\/1471-2458-14-1243","article-title":"Quality of life (QoL) assessment in a cohort of patients with phenylketonuria","volume":"14","author":"Cazzorla","year":"2014","journal-title":"BMC Public Health"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb0620","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymgme.2018.07.002","article-title":"The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: a PKU-COBESO study","volume":"125","author":"Huijbregts","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0625","article-title":"Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients","volume":"51","author":"Vieira","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ymgme.2025.109125_bb0630","article-title":"Health related quality of life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire","volume":"23","author":"Barta","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb0635","article-title":"Quality of life in children living with PKU - a single-center, cross-sectional, observational study from Hungary","volume":"29","author":"Becsei","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb0640","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clnesp.2018.06.005","article-title":"The impact of phenylketonuria on PKU patients\u2019 quality of life: using of the phenylketonuria-quality of life (PKU-QOL) questionnaires","volume":"27","author":"Alptekin","year":"2018","journal-title":"Clin. Nutr. ESPEN"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0645","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10198-021-01415-9","article-title":"The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study","volume":"23","author":"Olofsson","year":"2022","journal-title":"Eur. J. Health Econ."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0650","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s13760-018-0972-2","article-title":"Attention-deficit hyperactivity disorder in Brazilian patients with phenylketonuria","volume":"120","author":"da Silva","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0655","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ymgme.2012.12.006","article-title":"Psychiatric symptoms in adults with phenylketonuria","volume":"108","author":"Bilder","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0660","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.ymgme.2025.109125_bb0665","first-page":"57","article-title":"Living with phenylketonuria: lessons from the PKU community","volume":"17","author":"Ford","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0670","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2015.11.006","article-title":"Psychiatric disorders in adolescent and young adult patients with phenylketonuria","volume":"117","author":"Manti","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0675","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/DBP.0000000000000072","article-title":"Depression, anxiety, and stress in young adults with phenylketonuria: associations with biochemistry","volume":"35","author":"Clacy","year":"2014","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2025.109125_bb0680","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.ymgme.2013.10.011","article-title":"Mental health and social functioning in early treated phenylketonuria: the PKU-COBESO study","volume":"110","author":"Jahja","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0685","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2018.03.003","article-title":"Pegvaliase for the treatment of phenylketonuria: a pivotal, double-blind randomized discontinuation phase 3 clinical trial","volume":"124","author":"Harding","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0690","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2020.12.001","article-title":"Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU)","volume":"132","author":"Clocksin","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0695","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13023-018-0912-5","article-title":"White matter microstructural damage in early treated phenylketonuric patients","volume":"13","author":"Gonzalez","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0700","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymgme.2012.08.007","article-title":"A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria","volume":"107","author":"Bodner","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101916","article-title":"White and gray matter brain development in children and young adults with phenylketonuria","volume":"23","author":"Hawks","year":"2019","journal-title":"Neuroimage Clin."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb0710","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000204415.39853.4a","article-title":"Global and regional volume changes in the brains of patients with phenylketonuria","volume":"66","author":"Perez-Duenas","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109125_bb0715","article-title":"The effects of early-treated phenylketonuria on volumetric measures of the cerebellum","volume":"25","author":"Aldridge","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0720","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2016.02.004","article-title":"Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria","volume":"118","author":"Christ","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0725","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1067\/mpd.2000.108398","article-title":"Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia","volume":"137","author":"Agostoni","year":"2000","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb0730","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.57.8.1488","article-title":"Fish oil supplementation improves visual evoked potentials in children with phenylketonuria","volume":"57","author":"Beblo","year":"2001","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb0735","first-page":"S2","article-title":"Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU)","volume":"48","author":"Koletzko","year":"2009","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2012.10.021","article-title":"Visual functions in phenylketonuria-evaluating the dopamine and long-chain polyunsaturated fatty acids depletion hypotheses","volume":"108","author":"Gramer","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109125_bb0745","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmedgenet-2019-106770","article-title":"Retinal nerve fibre layer thickness associates with phenylketonuria control and cognition","volume":"57","author":"Nowak","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109125_bb0750","article-title":"Altered visual functions, macular ganglion cell and papillary retinal nerve fiber layer thickness in early-treated adult PKU patients","volume":"25","author":"Serfozo","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"51","key":"10.1016\/j.ymgme.2025.109125_bb0755","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009322","article-title":"Arterial stiffness assessment in patients with phenylketonuria","volume":"96","author":"Hermida-Ameijeiras","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb0760","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/CIRCULATIONAHA.121.054204","article-title":"Dysregulated phenylalanine catabolism plays a key role in the trajectory of cardiac aging","volume":"144","author":"Czibik","year":"2021","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ymgme.2025.109125_bb0765","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020351","article-title":"Cardiac magnetic resonance reveals incipient cardiomyopathy traits in adult patients with phenylketonuria","volume":"10","author":"Tanacli","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0770","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2018.09.006","article-title":"Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria","volume":"125","author":"Burton","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0775","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13023-019-1153-y","article-title":"Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data","volume":"14","author":"Trefz","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0780","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-012-9548-0","article-title":"Chronic kidney disease in adolescent and adult patients with phenylketonuria","volume":"36","author":"Hennermann","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0785","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00726-011-0892-4","article-title":"Asymmetric dimethylarginine in children with homocystinuria or phenylketonuria","volume":"42","author":"Kanzelmeyer","year":"2012","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0790","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00431-019-03365-0","article-title":"Asymmetric dimethylarginine as a potential biomarker for management and follow-up of phenylketonuria","volume":"178","author":"Andrade","year":"2019","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0795","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MNH.0000000000000380","article-title":"The role of renal response to amino acid infusion and oral protein load in normal kidneys and kidney with acute and chronic disease","volume":"27","author":"Gabbai","year":"2018","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0800","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/adc.50.3.171","article-title":"Infantile hypertrophic pyloric stenosis in Belfast, 1957-1969","volume":"50","author":"Dodge","year":"1975","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030529","article-title":"How does feeding development and progression onto solid foods in PKU compare with Non-PKU children during weaning?","volume":"11","author":"Evans","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb0810","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1651-2227.1994.tb13457.x","article-title":"Feeding problems in young PKU children","volume":"407","author":"MacDonald","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"issue":"22","key":"10.1016\/j.ymgme.2025.109125_bb0815","first-page":"3056","article-title":"Phenylketonuria is not a risk factor for gut mucosa inflammation: a preliminary observation","volume":"17","author":"Walkowiak","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0820","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ymgme.2015.10.001","article-title":"The challenges of managing coexistent disorders with phenylketonuria: 30 cases","volume":"116","author":"MacDonald","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2025.109125_bb0825","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ymgme.2011.09.015","article-title":"Specific prebiotics in a formula for infants with phenylketonuria","volume":"104","author":"MacDonald","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb0830","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.21037\/tp-21-426","article-title":"A low abundance of genus Bacteroides in gut microbiota is negatively correlated with blood phenylalanine levels in Uygur patients with phenylketonuria","volume":"10","author":"Su","year":"2021","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109125_bb0835","article-title":"Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects","volume":"29","author":"Timmer","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0840","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.numecd.2018.01.004","article-title":"Phenylketonuric diet negatively impacts on butyrate production","volume":"28","author":"Verduci","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb0845","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fcimb.2019.00101","article-title":"Phenylketonuria diet promotes shifts in Firmicutes populations","volume":"9","author":"Bassanini","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157513","article-title":"Phenylketonuria and gut microbiota: a controlled study based on next-generation sequencing","volume":"11","author":"Pinheiro de Oliveira","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb0855","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jand.2021.12.011","article-title":"Preliminary investigation of microbiome and dietary differences in patients with phenylketonuria on enzyme substitution therapy compared to traditional therapies","volume":"122","author":"McWhorter","year":"2022","journal-title":"J. Acad. Nutr. Diet."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091883","article-title":"Glycomacropeptide safety and its effect on gut microbiota in patients with phenylketonuria: a pilot study","volume":"14","author":"Montanari","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0865","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jn\/nxx039","article-title":"Metabolomic markers of essential fatty acids, carnitine, and cholesterol metabolism in adults and adolescents with phenylketonuria","volume":"148","author":"Stroup","year":"2018","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0870","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061311","article-title":"Cardiometabolic and nutritional morbidities of a large, adult, PKU cohort from Andalusia","volume":"14","author":"Dios-Fuentes","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0875","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jimd.12177","article-title":"Bone mineral density is within normal range in most adult phenylketonuria patients","volume":"43","author":"Lubout","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"15","key":"10.1016\/j.ymgme.2025.109125_bb0880","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153135","article-title":"A low-phenylalanine-containing whey protein hydrolysate stimulates osteogenic activity through the activation of p38\/Runx2 signaling in osteoblast cells","volume":"14","author":"Bu","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0885","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2021.01.014","article-title":"Mesenchymal stem cell energy deficit and oxidative stress contribute to osteopenia in the Pah(enu2) classical PKU mouse","volume":"132","author":"Dobrowolski","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0890","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nutres.2015.11.007","article-title":"Normal vitamin D levels and bone mineral density among children with inborn errors of metabolism consuming medical food-based diets","volume":"36","author":"Geiger","year":"2016","journal-title":"Nutr. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0895","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jocd.2017.02.001","article-title":"Effects of short-term calcium supplementation in children and adolescents with phenylketonuria","volume":"21","author":"Tanaka","year":"2018","journal-title":"J. Clin. Densitom."},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2025.109125_bb0900","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15476278.2021.1949865","article-title":"A new view of bone loss in phenylketonuria","volume":"17","author":"Dobrowolski","year":"2021","journal-title":"Organogenesis"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0905","first-page":"446","article-title":"Glutamine energy substrate anaplerosis increases bone density in the Pah(enu2) classical PKU mouse in the absence of phenylalanine restriction","volume":"63","author":"Dobrowolski","year":"2022","journal-title":"JIMD Rep."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2025.109125_bb0910","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1007\/s10545-010-9189-0","article-title":"Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density","volume":"33","author":"Lage","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb0915","doi-asserted-by":"crossref","first-page":"1909101","DOI":"10.1155\/2017\/1909101","article-title":"Amino acid medical foods provide a high dietary acid load and increase urinary excretion of renal net acid, calcium, and magnesium compared with Glycomacropeptide medical foods in phenylketonuria","volume":"2017","author":"Stroup","year":"2017","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb0920","first-page":"30","article-title":"Sex differences in body composition and bone mineral density in phenylketonuria: a cross-sectional study","volume":"15","author":"Stroup","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.copbio.2016.10.009","article-title":"Designing medical foods for inherited metabolic disorders: why intact protein is superior to amino acids","volume":"44","author":"Ney","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb0930","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103153","article-title":"A 3 year longitudinal prospective review examining the dietary profile and contribution made by special low protein foods to energy and macronutrient intake in children with phenylketonuria","volume":"12","author":"Daly","year":"2020","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.ymgme.2025.109125_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/nu14183874","article-title":"Dietary liberalization in tetrahydrobiopterin-treated PKU patients: does it improve outcomes?","volume":"14","author":"Evers","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144855","article-title":"Alkaline phosphatase: structure, expression and its function in bone mineralization","volume":"754","author":"Vimalraj","year":"2020","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/nu13031040","article-title":"Protein substitute requirements of patients with phenylketonuria on BH4 treatment: a systematic review and Meta-analysis","volume":"13","author":"Ilgaz","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb0950","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/PHMT.S49329","article-title":"Dietary intervention in the management of phenylketonuria: current perspectives","volume":"7","author":"Rocha","year":"2016","journal-title":"Pediatr. Health Med. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0955","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13023-018-0847-x","article-title":"Carbohydrate status in patients with phenylketonuria","volume":"13","author":"Couce","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb0960","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000442304","article-title":"Weight Management in Phenylketonuria: what should be monitored","volume":"68","author":"Rocha","year":"2016","journal-title":"Ann. Nutr. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb0965","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103443","article-title":"Is the phenylalanine-restricted diet a risk factor for overweight or obesity in patients with phenylketonuria (PKU)? A systematic review and Meta-analysis","volume":"13","author":"Rodrigues","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb0970","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10571-017-0573-2","article-title":"Effect of blood phenylalanine levels on oxidative stress in classical Phenylketonuric patients","volume":"38","author":"Kumru","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0975","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11011-006-9035-0","article-title":"Investigation of oxidative stress parameters in treated phenylketonuric patients","volume":"21","author":"Sitta","year":"2006","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb0980","first-page":"663","article-title":"Oxidative stress in intoxication type inborn errors of metabolism using thiol-disulfide ratio","volume":"30","author":"Cam","year":"2021","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb0985","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","article-title":"Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients","volume":"679","author":"Sitta","year":"2009","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb0990","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.22.4.426","article-title":"Cognitive functions and the antioxidant system in phenylketonuric patients","volume":"22","author":"Gassio","year":"2008","journal-title":"Neuropsychology"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb0995","first-page":"58","article-title":"Nutritional Management of Phenylketonuria","volume":"68","author":"Macleod","year":"2010","journal-title":"Ann. Nestle Eng."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/nu11050995","article-title":"Over restriction of dietary protein allowance: the importance of ongoing reassessment of natural protein tolerance in phenylketonuria","volume":"11","author":"Pinto","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb1005","series-title":"ACMG Annual Clinical Genetics Meeting","article-title":"Dietary intakes and adverse events in pegvaliase-treated phenylketonuria adults who had low blood phenylalanine concentrations (poster)","author":"Thomas","year":"2020"},{"key":"10.1016\/j.ymgme.2025.109125_bb1010","series-title":"Australasian Consensus Guidelines for the Management of Phenylketonuria (PKU) throughout the Lifespan","author":"Inwood","year":"2017"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgme.2016.04.008","article-title":"Updated, web-based nutrition management guideline for PKU: an evidence and consensus based approach","volume":"118","author":"Singh","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1020","first-page":"287","article-title":"Nutrient intake and growth of infants with phenylketonuria undergoing therapy","volume":"27","author":"Acosta","year":"1998","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030552","article-title":"Growth, protein and energy intake in children with PKU taking a weaning protein substitute in the first two years of life: a case-control study","volume":"11","author":"Evans","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10545-005-0122-x","article-title":"The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria","volume":"28","author":"Hoeksma","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0015","article-title":"Growth and final height among children with phenylketonuria","volume":"140","author":"Thiele","year":"2017","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.clnu.2013.09.011","article-title":"Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients","volume":"33","author":"Aldamiz-Echevarria","year":"2014","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymgme.2013.05.017","article-title":"Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU","volume":"109","author":"Aldamiz-Echevarria","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1024063726046","article-title":"Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria","volume":"26","author":"Dobbelaere","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/07315724.2013.857281","article-title":"Randomized controlled trial of a protein substitute with prolonged release on the protein status of children with phenylketonuria","volume":"33","author":"Giovannini","year":"2014","journal-title":"J. Am. Coll. Nutr."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2025.109125_bb1060","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ymgme.2011.09.014","article-title":"Does a lower carbohydrate protein substitute impact on blood phenylalanine control, growth and appetite in children with PKU?","volume":"104","author":"Gokmen-Ozel","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10545-007-0549-3","article-title":"Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature","volume":"30","author":"Huemer","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ajcn\/37.5.778","article-title":"Protein requirements in infants and children: a longitudinal study of children treated for phenylketonuria","volume":"37","author":"Kindt","year":"1983","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ymgme.2012.10.006","article-title":"Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome","volume":"107","author":"Rocha","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb1080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ymgme.2017.07.007","article-title":"The relationship between dietary intake, growth and body composition in phenylketonuria","volume":"122","author":"Evans","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2025.109125_bb1085","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.ymgme.2013.10.009","article-title":"Early dietary treated patients with phenylketonuria can achieve normal growth and body composition","volume":"110","author":"Rocha","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ejcn.2013.218","article-title":"PKU patients on a relaxed diet may be at risk for micronutrient deficiencies","volume":"68","author":"Rohde","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb1095","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102459","article-title":"Nutritional and metabolic characteristics of UK adult phenylketonuria patients with varying dietary adherence","volume":"11","author":"Green","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1100","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.clnu.2020.11.003","article-title":"Dietary protein and protein substitute requirements in adults with phenylketonuria: a review of the clinical guidelines","volume":"40","author":"Firman","year":"2021","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1105","first-page":"52","article-title":"Evidence that protein requirements have been significantly underestimated","volume":"13","author":"Elango","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3945\/jn.116.240218","article-title":"The indicator amino acid oxidation method with the use of l-[1-13C]leucine suggests a higher than currently recommended protein requirement in children with phenylketonuria","volume":"147","author":"Turki","year":"2017","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nut.2007.03.009","article-title":"Protein metabolism in adult patients with phenylketonuria","volume":"23","author":"van Rijn","year":"2007","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1120","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093189","article-title":"Nitrogen balance after the administration of a prolonged-release protein substitute for phenylketonuria as a single dose in healthy volunteers","volume":"13","author":"Scheinin","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1017\/S0954422418000173","article-title":"Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria","volume":"32","author":"MacDonald","year":"2019","journal-title":"Nutr. Res. Rev."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1130","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092686","article-title":"An observational study evaluating the introduction of a prolonged-release protein substitute to the dietary Management of Children with phenylketonuria","volume":"12","author":"MacDonald","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.ymgme.2025.109125_bb1135","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1515\/jpem-2020-0319","article-title":"Tyrosine metabolism in health and disease: slow-release amino acids therapy improves tyrosine homeostasis in phenylketonuria","volume":"33","author":"Porta","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1140","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061653","article-title":"Amino acid plasma profiles from a prolonged-release protein substitute for phenylketonuria: a randomized, single-dose, four-way crossover trial in healthy volunteers","volume":"12","author":"Scheinin","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jhn.12510","article-title":"Fifteen years of using a second stage protein substitute for weaning in phenylketonuria: a retrospective study","volume":"31","author":"Evans","year":"2018","journal-title":"J. Hum. Nutr. Diet."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1150","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092035","article-title":"Improved eating behaviour and nutrient intake in noncompliant patients with phenylketonuria after reintroducing a protein substitute: observations from a multicentre study","volume":"11","author":"Green","year":"2019","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb1155","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ejcn.2016.54","article-title":"Protein substitutes for phenylketonuria in Europe: access and nutritional composition","volume":"70","author":"Pena","year":"2016","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1160","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020484","article-title":"Protein substitutes in PKU; their historical evolution","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb1165","doi-asserted-by":"crossref","first-page":"G590","DOI":"10.1152\/ajpgi.00211.2015","article-title":"Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice","volume":"309","author":"Sawin","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1170","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221125524","article-title":"Quality of life aspects of a low protein diet using GMP in patients with phenylketonuria","volume":"50","author":"Bensi","year":"2022","journal-title":"J. Int. Med. Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb1175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ymgme.2007.06.004","article-title":"Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU","volume":"92","author":"Lim","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1180","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091179","article-title":"Exploring drivers of liking of low-phenylalanine products in subjects with Phenyilketonuria using check-all-that-apply method","volume":"10","author":"Proserpio","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb1185","doi-asserted-by":"crossref","first-page":"6352919","DOI":"10.1155\/2018\/6352919","article-title":"Comparison of Glycomacropeptide with phenylalanine free-synthetic amino acids in test meals to PKU patients: no significant differences in biomarkers, including plasma Phe levels","volume":"2018","author":"Ahring","year":"2018","journal-title":"J. Nutr. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1190","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030520","article-title":"The effect of glycomacropeptide versus amino acids on phenylalanine and tyrosine variability over 24 hours in children with PKU: a randomized controlled trial","volume":"11","author":"Daly","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13023-019-1011-y","article-title":"Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU","volume":"14","author":"Daly","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1200","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092704","article-title":"The impact of the use of glycomacropeptide on satiety and dietary intake in phenylketonuria","volume":"12","author":"Daly","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/nu13062075","article-title":"A three-year longitudinal study comparing bone mass, density, and geometry measured by DXA, pQCT, and bone turnover markers in children with PKU taking L-amino acid or glycomacropeptide protein substitutes","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1210","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041323","article-title":"Growth and body composition in PKU children-a three-year prospective study comparing the effects of L-amino acid to glycomacropeptide protein substitutes","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb1215","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111794","article-title":"The use of Glycomacropeptide in patients with phenylketonuria: a systematic review and meta-analysis","volume":"10","author":"Pena","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13023-021-01721-8","article-title":"Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective","volume":"16","author":"Pena","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045165","article-title":"Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet","volume":"7","author":"Solverson","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1230","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3945\/ajcn.2008.27280","article-title":"Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids","volume":"89","author":"van Calcar","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb1235","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ejcn.2017.38","article-title":"Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source","volume":"71","author":"Pinto","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1240","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/jhn.12438","article-title":"Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?","volume":"30","author":"Daly","year":"2017","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.ymgme.2025.109125_bb1245","first-page":"105","article-title":"Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: a case report","volume":"13","author":"Pinto","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1250","article-title":"Tyrosine supplementation for phenylketonuria","volume":"1","author":"Remmington","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgme.2025.109125_bb1255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jnutbio.2017.09.020","article-title":"Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice","volume":"53","author":"van Vliet","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2021.11.003","article-title":"The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations","volume":"135","author":"van Vliet","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb1265","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102541","article-title":"Large neutral amino acid therapy increases tyrosine levels in adult patients with phenylketonuria: a long-term study","volume":"11","author":"Burlina","year":"2019","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb1270","doi-asserted-by":"crossref","DOI":"10.3390\/nu14081595","article-title":"Validation of a low-protein semi-quantitative food frequency questionnaire","volume":"14","author":"Evans","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1275","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/TIN.0000000000000014","article-title":"Food frequency questionnaire: an alternative method to assess protein intake in adolescents and adults with phenylketonuria","volume":"29","author":"Viau","year":"2014","journal-title":"Top. Clin. Nutr."},{"issue":"20","key":"10.1016\/j.ymgme.2025.109125_bb1280","doi-asserted-by":"crossref","DOI":"10.3390\/nu14204268","article-title":"Impact of fruit and vegetable protein vs. milk protein on metabolic control of children with phenylketonuria: a randomized crossover controlled trial","volume":"14","author":"Pinto","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.numecd.2016.11.002","article-title":"Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria","volume":"27","author":"Moretti","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb1290","first-page":"62","article-title":"The challenge of long-term tetrahydrobiopterin (BH4) therapy in phenylketonuria: effects on metabolic control, nutritional habits and nutrient supply","volume":"4","author":"Thiele","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb1295","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-015-0378-7","article-title":"Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile","volume":"10","author":"Pena","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb1300","doi-asserted-by":"crossref","DOI":"10.3390\/nu13113977","article-title":"Special low protein foods prescribed in England for PKU patients: an analysis of prescribing patterns and cost","volume":"13","author":"Wood","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb1305","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.earlhumdev.2015.08.013","article-title":"Human breast milk: a review on its composition and bioactivity","volume":"91","author":"Andreas","year":"2015","journal-title":"Early Hum. Dev."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pcl.2012.10.002","article-title":"Human milk composition: nutrients and bioactive factors","volume":"60","author":"Ballard","year":"2013","journal-title":"Pediatr. Clin. N. Am."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1315","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093071","article-title":"25 years of research in human lactation: from discovery to translation","volume":"13","author":"Geddes","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1320","doi-asserted-by":"crossref","DOI":"10.3390\/nu8050279","article-title":"Review of infant feeding: key features of breast Milk and infant formula","volume":"8","author":"Martin","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb1325","series-title":"Infant and young child feeding","author":"WHO","year":"2023"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb1330","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3345\/cep.2020.00059","article-title":"Components of human breast milk: from macronutrient to microbiome and microRNA","volume":"63","author":"Kim","year":"2020","journal-title":"Clin. Exp. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1335","article-title":"Stress degree demonstrated in mothers with phenylketonuria or hyperphenylalaninemia infant when requested for total or partial breastfeeding replacement","volume":"10","author":"Schulpis","year":"2021","journal-title":"Case Rep. Perinat. Med."},{"key":"10.1016\/j.ymgme.2025.109125_bb1340","first-page":"82","article-title":"Early feeding practices in infants with phenylketonuria across Europe","volume":"16","author":"Pinto","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"19","key":"10.1016\/j.ymgme.2025.109125_bb1345","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194138","article-title":"Breastfeeding in phenylketonuria: changing modalities, changing perspectives","volume":"14","author":"Zuvadelli","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1350","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020707","article-title":"Accidental consumption of aspartame in phenylketonuria: patient experiences","volume":"13","author":"Newbould","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1355","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061887","article-title":"Aspartame and Phe-containing degradation products in soft drinks across Europe","volume":"12","author":"van Vliet","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1360","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13197-011-0571-1","article-title":"Artificial sweeteners - a review","volume":"51","author":"Chattopadhyay","year":"2014","journal-title":"J. Food Sci. Technol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15644\/asc56\/2\/2","article-title":"Dental status and periodontal health of patients with phenylketonuria in Latvia","volume":"56","author":"Abola","year":"2022","journal-title":"Acta Stomatol. Croat."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1370","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1515\/jpem-2019-0439","article-title":"Oral health status of children with phenylketonuria","volume":"33","author":"Ballikaya","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1375","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00784-015-1564-7","article-title":"Investigation of the oral status and microorganisms in children with phenylketonuria and type 1 diabetes","volume":"20","author":"Singh-Husgen","year":"2016","journal-title":"Clin. Oral Investig."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1380","first-page":"147","article-title":"Developmental defects of enamel in phenylketonuria patients","volume":"81","author":"de Marco","year":"2014","journal-title":"J. Dent. Child. (Chic.)"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1385","article-title":"Dental disease indices and caries related oral microflora in children with phenylketonuria","volume":"68","author":"Lucas","year":"2001","journal-title":"ASDC J. Dent. Child."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1390","doi-asserted-by":"crossref","first-page":"587","DOI":"10.14219\/jada.archive.1968.0293","article-title":"Dental manifestations of phenylketonuria","volume":"77","author":"Myers","year":"1968","journal-title":"J. Am. Dent. Assoc."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1395","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1601-0825.2008.01509.x","article-title":"Enamel defects and salivary methylmalonate in methylmalonic acidemia","volume":"15","author":"Bassim","year":"2009","journal-title":"Oral Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb1400","first-page":"433","article-title":"The implication of phenylketonuria on oral health","volume":"21","author":"Kilpatrick","year":"1999","journal-title":"Pediatr. Dent."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1405","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jhn.12346","article-title":"Food acceptance and neophobia in children with phenylketonuria: a prospective controlled study","volume":"29","author":"Evans","year":"2016","journal-title":"J. Hum. Nutr. Diet."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109125_bb1410","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122857","article-title":"Mealtime anxiety and coping behaviour in parents and children during weaning in PKU: a case-control study","volume":"11","author":"Evans","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2025.109125_bb1415","first-page":"97","article-title":"Dietary treatment in Dutch children with phenylketonuria: an inventory of associated social restrictions and eating problems","author":"Haitjema","year":"2022","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1420","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-277X.1997.00050.x","article-title":"Abnormal feeding behaviours in phenylketonuria","volume":"10","author":"MacDonald","year":"1997","journal-title":"J. Hum. Nutr. Diet."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1425","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ymgme.2021.06.002","article-title":"Nutrition status of adults with phenylketonuria treated with pegvaliase","volume":"133","author":"Viau","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1430","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00004703-200004000-00001","article-title":"Comparison of eating attitudes and behaviors among adolescent and young women with type 1 diabetes mellitus and phenylketonuria","volume":"21","author":"Antisdel","year":"2000","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb1435","article-title":"Food habits and lifestyle in Hyperphenylalaninemia patients: should these be monitored?","volume":"9","author":"Dicintio","year":"2022","journal-title":"Children-Basel"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1440","first-page":"37","article-title":"A survey of eating attitudes and behaviors in adolescents and adults with phenylalanine hydroxylase deficiency","volume":"119","author":"Luu","year":"2020","journal-title":"WMJ"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1445","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cch.12727","article-title":"Psychosocial functioning in children with phenylketonuria: relationships between quality of life and parenting indicators","volume":"46","author":"Morawska","year":"2020","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymgme.2025.109125_bb1450","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"Association AP","year":"2013"},{"key":"10.1016\/j.ymgme.2025.109125_bb1455","series-title":"People-Centred and Integrated Health Services: An Overview of the Evidence","author":"Organization WH","year":"2015"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","article-title":"Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study","volume":"121","author":"Bilder","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1465","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-019-1188-0","article-title":"The cardiovascular phenotype of adult patients with phenylketonuria","volume":"14","author":"Azabdaftari","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1470","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.16061","article-title":"Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia","volume":"12","author":"Doulgeraki","year":"2014","journal-title":"Int. J. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb1475","first-page":"16","article-title":"Analysis of body composition and nutritional status in Brazilian phenylketonuria patients","volume":"6","author":"Mazzola","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb1480","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymgme.2012.07.006","article-title":"High prevalence of overweight and obesity in females with phenylketonuria","volume":"107","author":"Burrage","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb1485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jhn.12054","article-title":"Body mass index in adult patients with diet-treated phenylketonuria","volume":"26","author":"Robertson","year":"2013","journal-title":"J. Hum. Nutr. Diet."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb1490","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ymgme.2005.05.014","article-title":"Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy","volume":"86","author":"Lambruschini","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1495","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-016-0508-x","article-title":"Lipid profile status and other related factors in patients with Hyperphenylalaninaemia","volume":"11","author":"Couce","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1500","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jped.2014.06.006","article-title":"Metabolic syndrome in children and adolescents with phenylketonuria","volume":"91","author":"Kanufre","year":"2015","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264084","article-title":"Management precautions for risk of obesity are necessary among infants with PKU carrying the rs113883650 variant of the LAT1 gene: a cross-sectional study","volume":"17","author":"Bik-Multanowski","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109125_bb1510","article-title":"Carriership of the rs113883650\/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria","volume":"25","author":"Bik-Multanowski","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb1515","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.clnesp.2021.10.012","article-title":"Mechanisms of obesity in children and adults with phenylketonuria on contemporary treatment","volume":"46","author":"Alghamdi","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2017.04.012","article-title":"Protein intake and physical activity are associated with body composition in individuals with phenylalanine hydroxylase deficiency","volume":"121","author":"Jani","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1525","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2012.12.008","article-title":"Risk factors for developing mineral bone disease in phenylketonuric patients","volume":"108","author":"Miras","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"167","key":"10.1016\/j.ymgme.2025.109125_bb1530","first-page":"5","article-title":"Inborn errors of metabolism and sports","volume":"45","author":"Serrano","year":"2010","journal-title":"Apunts Med. Esport"},{"key":"10.1016\/j.ymgme.2025.109125_bb1535","first-page":"55","article-title":"Acute exercise in treated phenylketonuria patients: physical activity and biochemical response","volume":"5","author":"Mazzola","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1540","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s42000-020-00176-z","article-title":"Metabolic and catecholamine response to sympathetic stimulation in early-treated adult male patients with phenylketonuria","volume":"19","author":"Sumanszki","year":"2020","journal-title":"Hormones (Athens)"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1545","article-title":"Creatine levels in patients with phenylketonuria and mild hyperphenylalaninemia: a pilot study","volume":"11","author":"Verduci","year":"2021","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1550","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1025103018278","article-title":"Danger of high-protein dietary supplements to persons with hyperphenylalaninaemia","volume":"26","author":"Koch","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1555","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1515\/jpem-2018-0492","article-title":"A series of three case reports in patients with phenylketonuria performing regular exercise: first steps in dietary adjustment","volume":"32","author":"Rocha","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2025.109125_bb1560","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","article-title":"Quality of life in noncompliant adults with phenylketonuria after resumption of the diet","volume":"31","author":"Bik-Multanowski","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1565","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ejcn.2017.102","article-title":"Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases","volume":"72","author":"Mlcoch","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2025.109125_bb1570","article-title":"The financial and time burden associated with phenylketonuria treatment in the United States","volume":"21","author":"Rose","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1575","first-page":"7","article-title":"Suboptimal provision of medications and dietary products for phenylketonuria in Malta","volume":"28","author":"S","year":"2016","journal-title":"MaltaMed. J."},{"key":"10.1016\/j.ymgme.2025.109125_bb1580","first-page":"1","article-title":"The personal burden for caregivers of children with phenylketonuria: a cross-sectional study investigating time burden and costs in the UK","volume":"9","author":"MacDonald","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb1585","article-title":"Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: results from a survey with 228 patients and their caregivers","volume":"24","author":"Martins","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1590","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2021.10.001","article-title":"Natural history of children and adults with phenylketonuria in the NBS-PKU connect registry","volume":"134","author":"Kenneson","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1595","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10545-016-9995-0","article-title":"Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study","volume":"40","author":"Wang","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb1600","article-title":"Home delivery service of low protein foods in inherited metabolic disorders: does it help?","volume":"19","author":"MacDonald","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1605","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2013.05.003","article-title":"The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands","volume":"109","author":"Eijgelshoven","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb1610","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13023-015-0294-x","article-title":"Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries","volume":"10","author":"Bosch","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109125_bb1615","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-8-22","article-title":"Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support","volume":"8","author":"Anderson","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1620","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030626","article-title":"Hungry for change: the experiences of people with PKU, and their caregivers, when eating out","volume":"14","author":"Poole","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1625","doi-asserted-by":"crossref","first-page":"350","DOI":"10.17712\/nsj.2015.4.20150319","article-title":"Depression and anxiety among parents of phenylketonuria children","volume":"20","author":"Gunduz","year":"2015","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.ymgme.2025.109125_bb1630","article-title":"Health related quality of life of caregivers of children and adolescents with phenylketonuria: a systematic review","volume":"8","author":"Shaji Thomas","year":"2021","journal-title":"Glob. Pediatr. Health"},{"key":"10.1016\/j.ymgme.2025.109125_bb1635","first-page":"91","article-title":"Parenting a child with phenylketonuria: an investigation into the factors that contribute to parental distress","volume":"41","author":"Ambler","year":"2018","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1640","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10545-010-9267-3","article-title":"Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life","volume":"34","author":"ten Hoedt","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1645","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jpepsy\/jsaa100","article-title":"Triple P for parents of children with phenylketonuria: a nonrandomized trial","volume":"46","author":"Mitchell","year":"2021","journal-title":"J. Pediatr. Psychol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1650","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/mgg3.315","article-title":"Living with a rare disorder: a systematic review of the qualitative literature","volume":"5","author":"von der Lippe","year":"2017","journal-title":"Mol. Genet. Genomic Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1655","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-016-0548-2","article-title":"Experiences of caregivers of children with inherited metabolic diseases: a qualitative study","volume":"11","author":"Siddiq","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1660","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10545-015-9881-1","article-title":"Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups","volume":"39","author":"Khangura","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1665","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13023-019-1236-9","article-title":"Reducing complexity: explaining inborn errors of metabolism and their treatment to children and adolescents","volume":"14","author":"Zeltner","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2025.109125_bb1670","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jhn.12065","article-title":"Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys","volume":"27","author":"Bernstein","year":"2014","journal-title":"J. Hum. Nutr. Diet."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb1675","doi-asserted-by":"crossref","DOI":"10.3390\/nu14112182","article-title":"Efficacy of a new low-protein multimedia diet app for PKU","volume":"14","author":"Evans","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1680","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jhn.13015","article-title":"Knowledge, perceptions and behaviours regarding dietary management of adults living with phenylketonuria","volume":"35","author":"Firman","year":"2022","journal-title":"J. Hum. Nutr. Diet."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1685","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-277X.2008.00879.x","article-title":"Knowledge, compliance and serum phenylalanine concentrations in adolescents and adults with phenylketonuria and the effect of a patient-focused educational resource","volume":"21","author":"Durham-Shearer","year":"2008","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.ymgme.2025.109125_bb1690","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12986-017-0207-1","article-title":"Phenylketonuria patients\u2019 and their parents\u2019 knowledge and attitudes to the daily diet - multi-Centre study","volume":"14","author":"Witalis","year":"2017","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.ymgme.2025.109125_bb1695","series-title":"Summary of Product Characteristics Kuvan","author":"Agency","year":"2020"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb1700","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ymgme.2005.07.024","article-title":"Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin","volume":"86","author":"Belanger-Quintana","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1705","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2012.11.012","article-title":"Use of sapropterin in the management of phenylketonuria: seven case reports","volume":"108","author":"Gokmen Ozel","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1710","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10545-010-9224-1","article-title":"BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up","volume":"33","author":"Singh","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109125_bb1715","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ymgme.2005.06.026","article-title":"Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin","volume":"86","author":"Trefz","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1720","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00726-007-0625-x","article-title":"Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations","volume":"35","author":"Ploder","year":"2008","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1725","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41416-018-0357-6","article-title":"Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival","volume":"120","author":"Sirnio","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1730","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1735","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s40140-019-00345-w","article-title":"Metabolic disorders and anesthesia","volume":"9","author":"Yeoh","year":"2019","journal-title":"Curr. Anesthesiol. Rep."},{"issue":"9152","key":"10.1016\/j.ymgme.2025.109125_bb1740","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(98)10090-9","article-title":"Spastic paraparesis after anaesthesia","volume":"353","author":"Lee","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1745","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ANA.0000000000000399","article-title":"Is Propofol safe in patients with phenylketonuria?","volume":"30","author":"Rayadurg","year":"2018","journal-title":"J. Neurosurg. Anesthesiol."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb1750","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1111\/apa.16035","article-title":"Extremely low birthweight neonates with phenylketonuria require special dietary management","volume":"110","author":"Zemanova","year":"2021","journal-title":"Acta Paediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1755","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.clnu.2022.03.027","article-title":"Efficacy of branched chain amino acids supplementation in liver cirrhosis: a systematic review and meta-analysis","volume":"41","author":"Konstantis","year":"2022","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ymgme.2025.109125_bb1760","first-page":"64","article-title":"Reproductive experience of women living with phenylketonuria","volume":"17","author":"Ford","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb1765","first-page":"148","article-title":"Promoting psychological well-being in women with phenylketonuria: pregnancy-related stresses, coping strategies and supports","volume":"1","author":"Roberts","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1770","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13023-021-02108-5","article-title":"Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy","volume":"16","author":"Rohde","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1775","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-018-9455-2","article-title":"Impact of pregnancy on inborn errors of metabolism","volume":"19","author":"Wilcox","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ymgme.2025.109125_bb1780","series-title":"Protein and Amino Acid Requirements in Human Nutrition: Report of a Joint FAO\/WHO\/UNU Expert Consultation","author":"FAO\/WHO\/UNU","year":"2007"},{"key":"10.1016\/j.ymgme.2025.109125_bb1785","series-title":"Nutrition during Pregnancy: Part I Weight Gain: Part II Nutrient Supplements. Washington (DC)","author":"Lactation IoMUCoNSDPa","year":"1990"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1790","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1535370218758275","article-title":"Impacts of maternal dietary protein intake on fetal survival, growth, and development","volume":"243","author":"Herring","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1795","article-title":"Scientific opinion on dietary reference values for energy","volume":"11","author":"(EFSA) EFSA","year":"2013","journal-title":"EFSA J."},{"key":"10.1016\/j.ymgme.2025.109125_bb1800","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fendo.2018.00546","article-title":"Obesity and weight gain in pregnancy and postpartum: an evidence review of lifestyle interventions to inform maternal and child health policies","volume":"9","author":"Farpour-Lambert","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"23","key":"10.1016\/j.ymgme.2025.109125_bb1805","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235125","article-title":"The effect of maternal overweight and obesity pre-pregnancy and during childhood in the development of obesity in children and adolescents: a systematic literature review","volume":"14","author":"Mannino","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061627","article-title":"Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight\/obesity: a systematic review and meta-analysis","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2025.109125_bb1815","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1471-2458-11-S3-S17","article-title":"Effect of balanced protein energy supplementation during pregnancy on birth outcomes","volume":"11","author":"Imdad","year":"2011","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1820","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000032","article-title":"Energy and protein intake in pregnancy","author":"Kramer","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1825","article-title":"Antenatal dietary education and supplementation to increase energy and protein intake","author":"Ota","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb1830","doi-asserted-by":"crossref","first-page":"839S","DOI":"10.3945\/an.115.011817","article-title":"Protein and amino acid requirements during pregnancy","volume":"7","author":"Elango","year":"2016","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1835","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3945\/jn.114.198622","article-title":"Protein requirements of healthy pregnant women during early and late gestation are higher than current recommendations","volume":"145","author":"Stephens","year":"2015","journal-title":"J. Nutr."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb1840","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41436-018-0407-8","article-title":"Phenylalanine and tyrosine measurements across gestation by tandem mass spectrometer on dried blood spot cards from normal pregnant women","volume":"21","author":"McBride","year":"2019","journal-title":"Genet. Med."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109125_bb1845","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/jn\/102.9.1147","article-title":"Plasma amino acid response in young men given diets devoid of single essential amino acids","volume":"102","author":"Ozalp","year":"1972","journal-title":"J. Nutr."},{"issue":"5 Suppl Understanding","key":"10.1016\/j.ymgme.2025.109125_bb1850","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1067\/mob.2002.123054","article-title":"Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy","volume":"186","author":"Koren","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1855","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/01443610500060651","article-title":"Validation studies of the pregnancy unique-quantification of Emesis (PUQE) scores","volume":"25","author":"Koren","year":"2005","journal-title":"J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1860","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.05.051","article-title":"Validity of a modified pregnancy-unique quantification of Emesis and nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy","volume":"198","author":"Lacasse","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 4","key":"10.1016\/j.ymgme.2025.109125_bb1865","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S0020-7292(15)30023-0","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: \u201cthink nutrition first\u201d","volume":"131","author":"Hanson","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1870","article-title":"Scientific opinion on dietary reference values for iodine","volume":"12","author":"(EFSA) EFSA","year":"2014","journal-title":"EFSA J."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1875","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020511","article-title":"Towards an optimized fetal DHA accretion: differences on maternal DHA supplementation using phospholipids vs. triglycerides during pregnancy in different models","volume":"13","author":"Gazquez","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109125_bb1880","article-title":"Omega-3 fatty acid addition during pregnancy","volume":"11","author":"Middleton","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgme.2025.109125_bb1885","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100905","article-title":"Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: a randomised, double-blind, adaptive-design superiority trial","volume":"36","author":"Carlson","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"10132","key":"10.1016\/j.ymgme.2025.109125_bb1890","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(18)30312-X","article-title":"Origins of lifetime health around the time of conception: causes and consequences","volume":"391","author":"Fleming","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1895","doi-asserted-by":"crossref","DOI":"10.3390\/nu14051021","article-title":"The impact of the quality of nutrition and lifestyle in the reproductive years of women with PKU on the long-term health of their children","volume":"14","author":"Gama","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1900","first-page":"212","article-title":"Intrauterine programming","volume":"18","author":"Sedaghat","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ymgme.2025.109125_bb1905","series-title":"Handbook on Nutrition and Pregnancy","author":"Lammi-Keefe","year":"2018"},{"key":"10.1016\/j.ymgme.2025.109125_bb1910","series-title":"Diet, Nutrition, and Fetal Programming","author":"Rajendram","year":"2017"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb1915","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jimd.12544","article-title":"Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring\u2019s outcome in phenylketonuria","volume":"45","author":"Grohmann-Held","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Spec Iss 4","key":"10.1016\/j.ymgme.2025.109125_bb1920","first-page":"138","article-title":"Quality of life in phenylketonuria (PKU) patients residing in Iehran, Islamic republic of Iran","volume":"8","author":"Hatami","year":"2015","journal-title":"J. Med. Life"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1925","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymgme.2015.03.007","article-title":"6R-tetrahydrobiopterin treated PKU patients below 4 years of age: physical outcomes, nutrition and genotype","volume":"115","author":"Aldamiz-Echevarria","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb1930","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1515\/jpem-2018-0503","article-title":"Response to sapropterin hydrochloride (Kuvan(R)) in children with phenylketonuria (PKU): a clinical trial","volume":"32","author":"Eshraghi","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1935","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-017-0600-x","article-title":"Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial","volume":"12","author":"Muntau","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb1940","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s13023-021-01968-1","article-title":"Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial","volume":"16","author":"Muntau","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1945","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bcp.13886","article-title":"Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: a meta-analysis of randomized controlled trials","volume":"85","author":"Qu","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1950","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ymgme.2014.11.014","article-title":"Individualized long-term outcomes in blood phenylalanine concentrations and dietary phenylalanine tolerance in 11 patients with primary phenylalanine hydroxylase (PAH) deficiency treated with Sapropterin-dihydrochloride","volume":"114","author":"Stockler-Ipsiroglu","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb1955","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/jpem-2015-0337","article-title":"Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia - effect on median Phe\/Tyr ratios","volume":"29","author":"Tansek","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1960","first-page":"213","article-title":"Sapropterin dihydrochloride treatment in Turkish hyperphenylalaninemic patients under age four","volume":"57","author":"Unal","year":"2015","journal-title":"Turk. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb1965","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S1092852914000455","article-title":"Pilot study to evaluate the effects of tetrahydrobiopterin on adult individuals with phenylketonuria with measurable maladaptive behaviors","volume":"20","author":"Moseley","year":"2015","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1970","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ejhg.2014.114","article-title":"Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria","volume":"23","author":"Wettstein","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1975","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41436-018-0081-x","article-title":"Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria","volume":"21","author":"Garbade","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109125_bb1980","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13023-016-0394-2","article-title":"The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?","volume":"11","author":"Anjema","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb1985","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2019.12.011","article-title":"Does the 48-hour BH4 loading test miss responsive PKU patients?","volume":"129","author":"van Wegberg","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109125_bb1990","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/jpem-2016-0461","article-title":"Improved metabolic control in tetrahydrobiopterin (BH4), responsive phenylketonuria with sapropterin administered in two divided doses vs. a single daily dose","volume":"30","author":"Kor","year":"2017","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.ymgme.2025.109125_bb1995","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/hmg\/ddr165","article-title":"The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response","volume":"20","author":"Staudigl","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb2000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2019.04.004","article-title":"International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria","volume":"127","author":"Muntau","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb2005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymgme.2021.01.013","article-title":"Defining tetrahydrobiopterin responsiveness in phenylketonuria: survey results from 38 countries","volume":"132","author":"Evers","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109125_bb2010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jimd.12173","article-title":"The first European guidelines on phenylketonuria: usefulness and implications for BH(4) responsiveness testing","volume":"43","author":"Evers","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb2015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/09513590.2014.928688","article-title":"A new case of maternal phenylketonuria treated with sapropterin dihydrochloride (6R-BH4)","volume":"30","author":"Aldamiz-Echevarria","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.ymgme.2025.109125_bb2020","article-title":"First Japanese case of maternal phenylketonuria treated with sapropterin dihydrochloride and the normal growth and development of the child","volume":"21","author":"Nyuzuki","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109125_bb2025","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/ped.13678","article-title":"Successful control of maternal phenylketonuria by tetrahydrobiopterin","volume":"60","author":"Sakamoto","year":"2018","journal-title":"Pediatr. Int."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109125_bb2030","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/cts.13043","article-title":"Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria","volume":"14","author":"Qi","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb2035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2020.06.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of the phase 2 dose-finding studies with long-term follow-up","volume":"130","author":"Burton","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109125_bb2040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-018-0858-7","article-title":"Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study","volume":"13","author":"Longo","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb2045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymgme.2021.05.006","article-title":"Palynziq clinic: one year and 43 patients later","volume":"133","author":"Lah","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109125_bb2050","article-title":"First 1.5 years of pegvaliase clinic: experiences and outcomes","volume":"24","author":"Sacharow","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109125_bb2055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2018.06.010","article-title":"Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria","volume":"125","author":"Zori","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109125_bb2060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2022.08.001","article-title":"Pegvaliase dosing in adults with PKU: requisite dose for efficacy decreases over time","volume":"137","author":"Hollander","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109125_bb2065","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41436-018-0403-z","article-title":"Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria","volume":"21","author":"Longo","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109125_bb2070","article-title":"Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase","volume":"28","author":"Rocha","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb2075","article-title":"Continuation of pegvaliase treatment during pregnancy: a case report","volume":"26","author":"Boyer","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb2080","article-title":"Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: a case report","volume":"22","author":"Rohr","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb2085","article-title":"Reinstitution of pegvaliase therapy during lactation","volume":"33","author":"Rohr","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"14","key":"10.1016\/j.ymgme.2025.109125_bb2090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121762","article-title":"Inhibiting neutral amino acid transport for the treatment of phenylketonuria","volume":"3","author":"Belanger","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2025.109125_bb2095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4939-8820-4_18","article-title":"Early stage discovery and validation of pharmacological chaperones for the correction of protein Misfolding diseases","volume":"1873","author":"Aubi","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109125_bb2100","first-page":"468","article-title":"Investigation of the relationship between phenylalanine in venous plasma and capillary blood using volumetric blood collection devices","volume":"64","author":"Carling","year":"2023","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109125_bb2105","article-title":"Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"101289","author":"Smith","year":"2024","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb2110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ajcnut.2023.11.007","article-title":"Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria - a randomized controlled trial","volume":"119","author":"Trepp","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109125_bb2115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajcnut.2024.01.023","article-title":"Phenylketonuria in adults: what do we know?","volume":"119","author":"Lachmann","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2025.109125_bb2120","series-title":"High-quality healthcare for adults with PKU must be a priority, just as it is for children with PKU","author":"(ESPKU) TESfPaADTaP","year":"2024"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:46:34Z","timestamp":1762364794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":424,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1096719225001167"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109125","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European guidelines on diagnosis and treatment of phenylketonuria: First revision","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109125"}}